“The Whole World in One Fractal” — A TRYP Expo Recap

Last week, a big States of Mind team made the trip to Berlin for TRYP Expo 2026. Held May 15-17 at the iconic Funkhaus Berlin, TRYP is Europe’s largest gathering dedicated to the psychedelic industry, blending science, wellness, and human energy. Over three days, this expo brought together researchers, clinicians, practitioners, artists, and curious minds from across the continent — with more than 80 speakers, 150+ exhibitors, and countless conversations.

Our team took the stage with a keynote From Fringe to Framework: Building the Infrastructure of Psychedelic Practice. The core idea is simple but vital: as psychedelic-assisted therapy becomes more accessible across Europe, the field still lacks the independent verification, shared standards, and accountability — the real infrastructure, in short, to support it safely.

Good intentions are not a safety standard.
The quality of your psychedelic experience should never be a matter of luck.

But what does the rest of the community think — and what future are they here to build? To get to know the TRYP community better, we went around the space and asked guests three questions:

What brought you into psychedelics?
What unites you with the people here?
What do you wish to see in the future of the psychedelic industry?

Curious about the answers? So were we — and here’s what we heard.

Daniel Brunner, alternative medicine practitioner, Bodawerk

Daniel on Instagram and LinkedIn

Farhad, psychedelic bodywork practitioner

Farhad on Instagram

Good Mood Food Team

Good Mood Food Instagram

Laurin Angermeier, neuroscientist, co-founder of ‘inLighten Berlin’

Laurin on LinkedIn

Max de Rosnay, directory & certification lead, Pink Elephant

Max on LinkedIn

And some other wonderful guests

This article is provided for educational and informational purposes only and does not constitute medical or legal advice. Ketamine, psilocybin and other psychedelic substances are controlled or otherwise regulated in many jurisdictions, and their legal status, approved uses and permitted clinical use vary by country and region. Their place in treatment pathways depends on the jurisdiction, indication, available evidence and individual clinical circumstances. Nothing in this article encourages the unlawful acquisition, possession, supply or use of any substance. Any treatment involving these substances should be considered only with a suitably qualified healthcare professional and in accordance with applicable law and clinical guidance. Do not initiate, discontinue or modify treatment based solely on this article.

Anna Lindner

Anna is a journalist and editor focused on social media, tech, progressive wellness, and mental health. Her work explores how new scientific research and discoveries shape our understanding of mental health and different mental states worldwide.